课题基金 / 基金详情

Fc Receptors in Mast Cell Signaling and Function

Fc Receptors in Mast Cell Signaling and Function
肥大细胞信号传导和功能中的 Fc 受体
批准号:
6431716
负责人:
Dean D Metcalfe
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Dean D Metcalfe的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mast cells play a pivotal role in the pathogenesis of asthma and other allergic diseases. These reactions are generally initiated by antigen-dependent aggregation of the high affinity IgE receptor (Fc-epsilon-RI) expressed on the cell surface and subsequent release of pro-inflammatory mediators (e.g. histamine, prostanoids, proteases and cytokines). We have demonstrated that interferon-gamma up-regulates the high affinity receptor for IgG (Fc-gamma-RI) on cultured human mast cells and that aggregation of these receptors leads to mast cell mediator release. An objectof this study is to delineate the signaling pathways of Fc-epsilon-RI and Fc-gamma-RI receptors leading to the release of inflammatory mediators from human mast cells. The current model for the signaling pathway linking Fc-epsilon-RI to mast cell activation has largely been based on studies conducted in RBL 2H3 cells. RBL 2H3 cells are a transformed rodent cell line, which may not be, in all aspects, reflective of the mature human mast cells. The signaling pathways linking the Fc-gamma-RI receptor to mast cell activation have yet to be delineated. It is now possible to grow human mast cells from a CD34-positive, pluripotent cell population in primary culture with sufficient number and purity to study defined signaling events. Thus, we are now examining specific signaling pathways involved in Fc-epsilon-RI- and Fc-gamma-RI- dependent inflammatory mediator release from human mast cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
REGULATION OF CYTOKINE GENE EXPRESSION IN MAST CELLS
Developmental Immunotherapeutics for Allergic Diseases and Asthma
The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell Disorders
Activation of Mast Cells in Disease States: Pharmacological Modification
海外基金